Research Article
Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer
Table 3
Univariate and multivariate analyses of relapse-free survival rates using the Cox proportional hazards model in all patients.
| Characteristics | Univariate analysis | Multivariate analysis | Hazard ratio | 95% CI | value | Hazard ratio | 95% CI | value |
| Age (>60 versus ≤60 years) | 1.623 | 0.982–2.683 | 0.059 | 2.158 | 1.207–3.862 | 0.009 | Sex (female versus male) | 0.804 | 0.45–1.439 | 0.463 | | | | Advanced T stage (pT4 versus pT2-3) | 3.088 | 1.557–6.045 | 0.001 | 2.464 | 0.995–6.102 | 0.051 | Advanced N stage (pN2-3 versus pN0-1) | 3.688 | 2.157–6.304 | <0.001 | 1.491 | 0.208–2.156 | 0.502 | Lauren classification (diffuse versus nondiffuse) | 1.505 | 0.905–2.501 | 0.115 | 1.917 | 1.032–3.562 | 0.039 | Lymphatic invasion (yes versus no) | 2.956 | 1.272–6.869 | 0.012 | 1.479 | 0.543–0.032 | 0.444 | Venous invasion (yes versus no) | 1.821 | 0.782–4.238 | 0.165 | 0.483 | 0.778–5.498 | 0.145 | Tumor grade (moderate–poor versus well) | 4.199 | 1.026–17.184 | 0.046 | 1.754 | 0.112–2.911 | 0.498 | Adjuvant chemotherapy (yes versus no) | 0.839 | 0.51–1.381 | 0.490 | | | | LNR (>median versus ≤median) | 4.551 | 2.567–8.069 | <0.001 | 2.282 | 0.926–5.626 | 0.072 | Tumoral Cav-1 expression, primary tumor (high versus low) | 0.95 | 0.452–1.996 | 0.892 | 1.275 | 0.485–3.350 | 0.622 | Stromal Cav-1 expression, primary tumor (high versus low) | 1.529 | 0.881–2.652 | 0.131 | 0.956 | 0.516–2.116 | 0.902 | Tumoral Cav-1 expression, lymph node (high versus low) | 2.874 | 1.491–5.540 | 0.002 | 3.934 | 1.882–8.224 | <0.001 |
|
|
LNR: lymph node ratio.
|